|
Delayed
Nasdaq
21:00:00 10/06/2026 BST
|
5-day change | 1st Jan Change | ||
| 27.00 USD | +0.04% |
|
-.--% | +67.18% |
| 06-14 | KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell 2000 Growth Index | CI |
| 06-14 | KalVista Pharmaceuticals, Inc.(NasdaqGM:KALV) dropped from Russell Small Cap Comp Growth Index | CI |
| Market Cap | 1.44B 1.24B 1.17B 1.06B 1.99B 137B 2B 13.89B 5.35B 69.71B 5.4B 5.28B 221B | P/E 2024 |
-2.46x | P/E 2025 | -5.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.42B 1.22B 1.15B 1.05B 1.96B 136B 1.98B 13.74B 5.29B 68.93B 5.34B 5.22B 219B | EV / Sales 2024 |
-
| EV / Sales 2025 | 10.9x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : KalVista Pharma
| 1 day | +0.04% | ||
| 3 months | +0.04% | ||
| 6 months | +56.07% | ||
| Current year | +67.18% |
| Current year | 14.22 |  | 27 |
| 1 year | 10.41 | | 27 |
| 3 years | 7.21 | | 27 |
| 5 years | 4.12 | | 27 |
| 10 years | 0 | | 45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ed Feener
CTO | Chief Tech/Sci/R&D Officer | 66 | 31/10/2016 |
Ben Palleiko
CEO | Chief Executive Officer | 61 | 05/03/2024 |
John Hess
PSD | President | - | 10/06/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
John Hess
CHM | Chairman | - | 10/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/05/26 | Exercice | Executive/Senior Manager | 101,400 | 0.2006% | ||
| 26/05/26 | Sell | Executive/Senior Manager | -1,489 | 0.0029% | ||
| 26/05/26 | Sell | Executive/Senior Manager | -1,966 | 0.0039% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 73.62M 63.31M 59.74M 54.42M 102M 7.04B 103M 711M 274M 3.57B 276M 270M 11.34B |
| Net income | -127M -109M -103M -93.62M -175M -12.11B -177M -1.22B -471M -6.14B -476M -465M -19.51B | -164M -141M -133M -121M -227M -15.71B -229M -1.59B -611M -7.97B -617M -603M -25.3B |
| Net Debt | -203M -175M -165M -150M -281M -19.42B -283M -1.96B -755M -9.85B -763M -746M -31.28B | -16.01M -13.77M -12.99M -11.83M -22.12M -1.53B -22.32M -155M -59.53M -776M -60.11M -58.8M -2.47B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- KALV Stock
Select your edition
All financial news and data tailored to specific country editions
